[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Asia-Pacific Advanced Wound Care Market, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

April 2018 | 100 pages | ID: AFE35E95187EN
Data Bridge Market Research

US$ 2,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this region, Asia-Pacific advanced wound care market is estimated to grow at the highest CAGR in the forecast period 2018 to 2025.

The Asia-Pacific advanced wound care market is segmented on the basis of type, wound type, end user and distribution channels.

Based on type, the market is segmented into dressings, biologics and therapy devices

On the basis of Wound type, market is segmented into surgical wounds, diabetic ulcers, pressure ulcers, venous ulcers and burns

On the basis of end users, market is segmented into hospitals, wound care centers, ambulatory centres, home healthcare, clinics and community healthcare.

On the basis of distribution channels, market is segmented into direct drivers, retails. In 2018, direct tender is likely to rule the market and is also projected to grow with the highest CAGR in the forecast period 2018-2025.

Based on country, the Asia-Pacific advanced wound care market is segmented into 11 countries -
  • China
  • Japan
  • India
  • South Korea
  • Thailand
  • Australia
  • Malaysia
  • Singapore
  • Indonesia
  • Philipiness
  • Rest of Asia Pacific
Asia-Pacific advanced wound care market competition by top players include -
  • Acelity L.P. Inc dominated the advanced wound care market accounting largest market share followed by Smith and Nephew, and Molnlycke Healthcare AB along with other players such as
  • Convatec Inc
  • Baxter,
  • Coloplast,
  • Ethicon. Inc
  • Integra Life Sciences Corporation
  • Derma Sciences Inc.
  • Organogenesis Inc,
  • B.Braun Melsungen AG
  • Paul Hartmann Limited
1 INTRODUCTION

1.1 Overview Of Asia-Pacific Advanced Wound Care Market
1.2 Currency And Pricing
1.3 Limitation
1.4 Markets Covered

2 MARKET SEGMENTATION

2.1 Markets Covered
2.2 Geographic Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Research Methodology
2.6 Primary Interviews With Key Opinion Leaders
2.7 Secondary Sources
2.8 Assumptions

3 MARKET OVERVIEW

3.1 Drivers
  3.1.1 Rising Ageing And Geriatric Population
  3.1.2 Technological Advancement
  3.1.3 Government Support
  3.1.4 Rising Incidences Of Chronic Wound
  3.1.5 Increasing Trend
3.2 Restraints
  3.2.1 Low Awareness
  3.2.2 Slow Growth Rate And Shrinking Market
  3.2.3 Complex Regulatory Approval Process
  3.2.4 Competition With Other Moist Dressings
3.3 Opportunities
  3.3.1 Reimbursement
  3.3.2 Mergers And Acquisitions To Expand Business
  3.3.3 Unmet Needs
  3.3.4 Increasing Demand
3.4 Challenges
  3.4.1 Shortage Of Trained Staff
  3.4.2 The Development Of Substitute Products
3.5 Key Market Trends And Upcomming Technologies
  3.5.1 Smart Dressing Will Push Future Growth
  3.5.2 Hydrofiber Has Been The Most Significant Recent Innovation
  3.5.3 Alginate Dressing Is Expected To Grow Robustly In The Upcoming Years
  3.5.4 Foam Dressing Accounting The Largest Market Segment In The Upcoming Years

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE

6.1 Overview
6.2 Dressing
  6.2.1 Dressing On The Basis Of Product Type
    6.2.1.1 Film Dressings
    6.2.1.2 Foam Dressings
    6.2.1.3 Hydrogels
    6.2.1.4 Alginates
    6.2.1.5 Wound Contact Layer
    6.2.1.6 Super Absorbent Dressing
6.3 Biologics
  6.3.1 Biologics On The Basis Of Product Type
    6.3.1.1 Allografts
    6.3.1.2 Synthetic Skin Grafts
    6.3.1.3 Xenografts
    6.3.1.4 Growth Factors
      6.3.1.4.1 Platelet Derived Growth Factor (Pdgf)
      6.3.1.4.2 Platelet Rich Plasma (Prp)
      6.3.1.4.3 Epidermal Growth Factors (Egf)
      6.3.1.4.4 Basic Fibroblast Growth Factors (Bfgf)
      6.3.1.4.5 Granulocyte Colony Stimulating Factor (G-Csf)
      6.3.1.4.6 Talactoferrin Alfa
      6.3.1.4.7 Thrombin Peptide
      6.3.1.4.8 Keratinocy Growth Factor (Kgf)
6.4 Therapy Devices
  6.4.1 Therapy Devices On The Basis Of Product Type
    6.4.1.1 Negative Pressure Wound Therapy (Npwt)
      6.4.1.1.1 Portable Npwt Devices
      6.4.1.1.2 Disposable Npwt Devices
    6.4.1.2 Pressure Relief Devices
    6.4.1.3 Hyperbaric Oxygen Chambers
      6.4.1.3.1 Monoplace
      6.4.1.3.2 Multiplace
      6.4.1.3.3 Topical
    6.4.1.4 Wound Debridement Devices
      6.4.1.4.1 Hydrosurgical
      6.4.1.4.2 Ultrasound
      6.4.1.4.3 Mechanical
      6.4.1.4.4 Others
    6.4.1.5 Physical Therapies
      6.4.1.5.1 Laser Therapy
      6.4.1.5.2 Electrical Stimulation
      6.4.1.5.3 External Shock Wave Therapies
      6.4.1.5.4 Saline Mist Therapy

7 ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY WOUND TYPE

70

7.1 Introduction
7.2 Surgical Wound
  7.2.1 Class I
  7.2.2 Class Ii
  7.2.3 Class Iii
  7.2.4 Class Iv
7.3 Diabetic Ulcers
7.4 Pressure Ulcers
7.5 Venous Ulcers
7.6 Burns

8 ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY END USER

8.1 Overview
8.2 Hospitals
8.3 Wound Care Centers
8.4 Ambulatory Centers
8.5 Home Healthcare
8.6 Clinics
8.7 Community Healthcare

9 ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL

9.1 Overview
9.2 Direct Tenders
9.3 Retail

10 ASIA-PACIFIC ADVANCED WOUND CARE MARKET BY GEOGRAPHY

10.1 Asia-Pacific
  10.1.1 Japan
  10.1.2 China
  10.1.3 South Korea
  10.1.4 India
  10.1.5 Australia
  10.1.6 Thailand
  10.1.7 Singapore
  10.1.8 Malaysia
  10.1.9 Philippines Advanced Wound Care Market
  10.1.10 Indonesia
  10.1.11 Rest Of Asia-Pacific

11 ASIA-PACIFIC ADVANCED WOUND CARE MARKET, COMPANY SHARE

11.1 Company Share Analysis: Asia-Pacific (Apac)

12 COMPANY PROFILE

12.1 Acelity L.P. Inc. (Subsidary Of Allargan)
  12.1.1 Company Overview
  12.1.2 Company Share Analysis
  12.1.3 Product Portfolio
  12.1.4 Recent Developments
12.2 Smith And Nephew
  12.2.1 Company Overview
  12.2.2 Company Share Analysis
  12.2.3 Revenue Analysis
  12.2.4 Product Portfolio
  12.2.5 Recent Developments
12.3 Molnlycke Healthcare
  12.3.1 Company Overview
  12.3.2 Company Share Analysis
  12.3.3 Asia-Pacific Presence
  12.3.4 Product Portfolio
  12.3.5 Recent Developments
12.4 3M
  12.4.1 Company Overview
  12.4.2 Company Share Analysis
  12.4.3 Revenue Analysis
  12.4.4 Product Portfolio
  12.4.5 Recent Developments
12.5 Baxter
  12.5.1 Company Overview
  12.5.2 Revenue Analysis
  12.5.3 Product Portfolio
  12.5.4 Recent Developments
12.6 Coloplast
  12.6.1 Company Overview
  12.6.2 Revenue Analysis
  12.6.3 Product Portfolio
  12.6.4 Recent Developments
12.7 Convatec Inc.
  12.7.1 Company Overview
  12.7.2 Revenue Analysis
  12.7.3 Product Portfolio
  12.7.4 Recent Developments
12.8 Derma Sciences Inc (Subsidiary Of Integra Life Sciences)
  12.8.1 Company Overview
  12.8.2 Asia-Pacific Presence
  12.8.3 Product Portfolio
  12.8.4 Recent Developments
12.9 Ethicon Inc (Subsidiary Of Johnson And Johnson Services, Inc )
  12.9.1 Company Overview
  12.9.2 Asia-Pacific Presence
  12.9.3 Product Portfolio
  12.9.4 Recent Developments
12.10 Integra Life Sciences Corporation
  12.10.1 Company Overview
  12.10.2 Revenue Analysis
  12.10.3 Product Portfolio
  12.10.4 Recent Developments
12.11 Paul Hartmann Limited
  12.11.1 Company Overview
  12.11.2 Revenue Analysis
  12.11.3 Product Portfolio
  12.11.4 Recent Development
12.12 Organogenesis Inc
  12.12.1 Company Overview
  12.12.2 Asia-Pacific Presence
  12.12.3 Product Portfolio
  12.12.4 Recent Developments

13 RELATED REPORTS

LIST OF FIGURES

Figure 1 Asia-Pacific Advanced Wound Care Market: Segmentation
Figure 2 Asia-Pacific Advanced Wound Care Market: Geograhic Scope
Figure 3 Asia-Pacific Advanced Wound Care Market: Data Triangulation
Figure 4 Asia-Pacific Advanced Wound Care Market: Snapshot
Figure 5 Asia-Pacific Advanced Wound Care Market: Bottom Up Approach
Figure 6 Asia-Pacific Advanced Wound Care Market: Top Down Approach
Figure 7 Asia-Pacific Advanced Wound Care Market: Interviews By Region And Designation
Figure 8 Drivers, Restraints, Opportunities And Challenges Of Asia-Pacific Advanced Wound Care Market
Figure 9 Technological Development And Growing Incidences Of Chronic Wounds Is Expected To Drive The Market For Asia-Pacific Advanced Wound Care In The Forecast Period 2017 To 2025
Figure 10 Dressing Market Segment Is Expected To Account For The Largest Share Of The Asia-Pacific Advanced Wound Care Market In 2025
Figure 11 Asia Pacific Is The Highest Growing And Most Profitable Revenue Pockets For Advanced Wound Care In The Forecast Period To 2025
Figure 12 Asia-Pacific Advanced Wound Care Market: By Product Type, Snapshot 2017
Figure 13 Asia-Pacific Advanced Wound Care Market: By Wound Type, Snapshot 2017
Figure 14 Asia-Pacific Advanced Wound Care Market: By End User, Snapshot 2017
Figure 15 Asia-Pacific Advanced Wound Care Market Snapshot (2017)
Figure 16 Asia-Pacific Advanced Wound Care Market: By Geography (2017)
Figure 17 Asia-Pacific Advanced Wound Care Market: By Geography (2018)
Figure 18 Asia-Pacific Advanced Wound Care Market: By Country (2017 & 2025)
Figure 19 Asia-Pacific Advanced Wound Care Market: By Type (2018 - 2025)
Figure 20 Apac Advanced Wound Care Market: Company Share 2017 (%)


More Publications